Testing effectiveness (Phase 2)Study completedNCT00348192What this trial is testingSB-742457 And Donepezil In Alzheimer's DiseaseWho this might be right forAlzheimer's Disease GlaxoSmithKline 200
Testing effectiveness (Phase 2)Active Not RecruitingNCT06881836What this trial is testingONO-2020 in Participants With Mild to Moderate Alzheimer's DiseaseWho this might be right forAlzheimer Disease Ono Pharmaceutical Co., Ltd. 260
Testing effectiveness (Phase 2)Study completedNCT00325728What this trial is testingEfficacy and Safety of Ramelteon in Subjects With Mild to Moderate Alzheimer's DiseaseWho this might be right forChronic Insomnia Takeda 74
Large-scale testing (Phase 3)Not Yet RecruitingNCT05303701What this trial is testingGV1001 Subcutaneous for the Treatment of Moderate to Severe Alzheimer's Disease(AD)Who this might be right forModerate to Severe Alzheimer's Disease Samsung Pharmaceutical Co., Ltd. 750
Testing effectiveness (Phase 2)Ended earlyNCT05670912What this trial is testingEfficacy and Safety of Wei Li Bai Capsules in the Treatment of Alzheimer's DiseaseWho this might be right forAlzheimer Disease Capital Medical University 105
Testing effectiveness (Phase 2)Study completedNCT01343966What this trial is testingEvaluate the Efficacy and Safety of MABT5102A in Patients With Mild to Moderate Alzheimer's Disease (ABBY)Who this might be right forAlzheimer's Disease Genentech, Inc. 448
Early research (Phase 1)Study completedNCT04566003What this trial is testingEvaluation Comparing Tau PET Radiotracers, [18F]GTP1 and [18F]PI-2620 or [18F]MK-6240 in Subjects With Normal Cognition or Prodromal to Moderate Alzheimer's DiseaseWho this might be right forAlzheimer Disease (AD) Genentech, Inc. 40
Testing effectiveness (Phase 2)Study completedNCT01696123What this trial is testingEfficacy and Tolerability of MLC601 in Patients With Mild to Moderate Alzheimer Disease Who Were Unable to Tolerate or Failed to Benefit From Treatment With RivastigmineWho this might be right forAlzheimer Disease Shahid Beheshti University of Medical Sciences 125
Early research (Phase 1)Study completedNCT02820896What this trial is testingRO7105705 in Healthy Participants and Participants With Mild-to-Moderate Alzheimer's DiseaseWho this might be right forAlzheimer's Disease Genentech, Inc. 74
Testing effectiveness (Phase 2)Study completedNCT01436045What this trial is testingSafety and Effectiveness Study of Intranasal Insulin Glulisine on Cognitive and Memory in Mild-Mod AD Patients.Who this might be right forAlzheimer's Disease HealthPartners Institute 12
Testing effectiveness (Phase 2)Study completedNCT06745583What this trial is testingAssess the Safety of EI-1071 and the Effects of EI-1071 on Neuroinflammation in Alzheimer's Disease PatientsWho this might be right forMild, Moderate, or Severe Alzheimer's Disease Elixiron Immunotherapeutics Inc. 7
Testing effectiveness (Phase 2)Study completedNCT00749216What this trial is testingSolanezumab Safety Study in Japanese Patients With Alzheimer's DiseaseWho this might be right forAlzheimer's Disease Eli Lilly and Company 33
Testing effectiveness (Phase 2)Study completedNCT04388254What this trial is testingSimufilam (PTI-125), 100 mg, for Mild-to-moderate Alzheimer's Disease PatientsWho this might be right forAlzheimer Disease Cassava Sciences, Inc. 220
Not applicableAvailableNCT03539380What this trial is testingTRx0237 for the Treatment of Early and Mild-Moderate Alzheimer's DiseaseWho this might be right forAlzheimer Disease TauRx Therapeutics Ltd
Testing effectiveness (Phase 2)Study completedNCT04251182What this trial is testingClinical Study Evaluating Efficacy and Safety of T3D-959 in Mild-to-moderate AD SubjectsWho this might be right forAlzheimer Disease T3D Therapeutics, Inc. 250
Testing effectiveness (Phase 2)Study completedNCT03001557What this trial is testingStudy of Lemborexant for Irregular Sleep-Wake Rhythm Disorder and Mild to Moderate Alzheimer's Disease DementiaWho this might be right forIrregular Sleep-Wake Rhythm Disorder Eisai Inc. 63
Post-approval studies (Phase 4)Ended earlyNCT01181921What this trial is testingThe CIRCADIAN Study: Evaluation of Modulating Effect of Galantamine on Circadian Rhythm in Patients With Mild to Moderate Alzheimer's DiseaseWho this might be right forAlzheimer Disease Janssen-Cilag, S.A. 1
Not applicableEnded earlyNCT02249468What this trial is testingAn Exploratory Study to Compare the Differences in Nutritional Status Between Patients With Mild and Moderate Alzheimer's Disease (AD) and Cognitively Intact Healthy People in an Asian PopulationWho this might be right forMild and Moderate Alzheimer's DiseaseCognitively Healthy People Danone Nutricia Research 191
Large-scale testing (Phase 3)Study completedNCT00838110What this trial is testingEvaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's DiseaseWho this might be right forAlzheimer's Disease Pfizer 742
Not applicableStudy completedNCT06151808What this trial is testingAnalysis of XTR006 PET Imaging in Non-cognitively Impaired Subjects, MCI Due toAD, and Mild to Moderate AD SubjectsWho this might be right forAlzheimer Disease Sinotau Pharmaceutical Group 42